Diabetes Helpline Number

(for appointment only) : 1800 425 0005

MV Diabetes
Journal
  • Shabana Tharkar, Vijay Viswanathan - Chennai Slim & Fit Programme (Awareness & Perceptions related to obesity among urban children & adolescents - TAPI Journal Vol 2, Issue 1, January, April, 2010.
  • Shabana Tharkar, Kumpatla Satyavani, P.Muthukumaran, Vijay Viswanathan - High Prevalence of Metabolic Syndrome and Cardiovascular Risk among police personnel compared to general population in India - JAPI - Vol - 56- November-2008.
  • Vijay Viswanathan, J. Janifer Jasmine, C. Snehalatha, A. Ramachandran. Prevalence of pathogens in diabetic foot infection in south Indian type 2 diabetic patients - JAPI, Vol. 50, Aug. 2002, 1013 - 1016.
  • Vijay Viswanathan, Uma Mahesh, M Jayaraman, K Shina, A Ramachandran. Beneficial role of granulocyte colony stimulating factor in foot infection in diabetic patients. JAPI, Vol. 51, January 2003.
  • Vijay Viswanathan, Sanjeev V, Kelkar DK, Seena R, Mamtha B Nair, A Ramachandran. Validation of indigenously made biothesiometer. The Asian Journal of Diabetology, 2003; 5(3): 13 - 14.
  • Vijay Viswanathan, HR Badrinath, C. Snehalatha, R.M. Bhoopathy , B. Mamta Nair, R Seena, M.P. Varadha Rani, A Ramachandran. Effect of treatment with the combination of Alpha - lipoic acid, chromium and inositol on diabetic peripheral neuropathy. The Asian Journal and Diabetology, September 2003, Vol. 5 (9); Pg. 9 - 15.
  • Vijay Viswanathan, Seena R, Mamtha B Nair, Snehalatha C, Bhoopathy RM, Ramachandran A. Nerve conduction abnormalities in different stages of glucose intolerance. Neurology India, 2004; 52 (4): 466 - 469.
  • Vijay Viswanathan, N. Thomas, N Tandon, A Asirvatham, Seena Rajasekar, A Ramachandran, K Senthilvasan, V.S. Murugan, Muthulakshmi. Profile of diabetic foot complications and its associated complications - A multicentric study from India. JAPI 2005; 53: 933 - 936.
  • Vijay Viswanathan. Diabetic nephropathy in type 2 diabetes: the Indian experience. JAPI vol. 49; December 2001, 1185 - 1187.
  • Vijay Viswanathan, B Mamtha Nair. Diabetic Nephropathy: The medical catastrophe in type 2 diabetes. Endocrine news letter, vol 11, No. 3, 2001.
  • Vijay Viswanathan, C Snehalatha, K Shina, A Ramachandran. Persistent microalbuminuria in type 1 diabetic subjects in south India. JAPI 2002; 50: 1259 - 1261.
  • Vijay Viswanathan, C Snehalatha, MP Varadharani, B Mamtha Nair, M Jayaraman, A Ramachandran. Prevalence of albuminuria among vegetarian and non-vegetarian south Indian diabetic patients. Indian J Nephrol 2002; 12: 73 - 76.
  • Vijay Viswanathan. Diabetes could cost you your kidneys, act now!. JAPI November 2003, vol. 51, 1043 - 1044.
  • Vijay Viswanathan, C Snehalatha, B Mamtha Nair, A Ramachandran. Validation of a method to determine albumin excretion rate in type 2 diabetes mellitus. The Indian Journal of Nephrology 13; 2003: 85 - 88.
  • Vijay Viswanathan, C Snehalatha, R Kumutha, B Mamtha Nair, A Ramachandran. Impact of joint national committee VII recommendations on diabetic microvascular complications. JAPI 2004; 52: 873 - 876.
  • Vijay Viswanathan, C Snehalatha, R Kumutha, Muthu Jayaraman, A Ramachandran. Serum albumin levels in different stages of type 2 diabetic nephropathy patients. Indian J Nephrol 2004; 14: 89 - 92.
  • Vijay Viswanathan. Prevention of diabetic nephropathy: A Diabetologist’s perspective. Indian J Nephrol 2004; 14: 157 - 162.
  • Vijay Viswanathan, C Snehalatha, Mamtha B Nair, A Ramachandran. Comparative assessment of cystatin C and creatinine for determining renal function. Indian J Nephrol 2005; 15: 91 - 94.
  • Vijay Viswanathan, Sheethal Suresh, Mamtha B Nair, Snehalatha C, Ramachandran A. Microalbuminruia: A Risk factor for abnormal pulse wave velocity. Indian J. Cardiol 2005; 8: 9 -12.
  • Vijay Viswanathan, Sivagami, Seena Rajasekar. Diabetic Foot: An Indian Scenario. The Asian Journal of Diabetology (special issue), Vol 7, No.3, Pg 9 - 11, 2005.
  • Vijay Viswanathan. Management of diabetes in chronic renal failure. Indian J Nephrol 2005; 15, Supplement1: S23 - S31.
  • Vijay Viswanathan, P.T. Chacko, M. Lavanya, Priyanka Tilak. A Proof of Concept, preliminary study to determine the effect of yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy). JAPI 2006; 54: 965 - 966.
  • Vijay Viswanathan, M.Clementina, B.Mamtha Nair, K.Satyavani. Risk of future Diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance ? JAPI, Vol. 55, 833-837, December, 2007.
  • Risk of Diabetes in Subjects with Sedentary Profession and the Synergistic Effect of Positive Family History of Diabetes. Vigneswari A, Satyavani K, Manikandan R,Rajeswari Rajan, Vijay V. Diabetes Technology & Therapeutics. 2014. Vol 16(1): 26 – 32.PMID: 24116832
  • Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis— A report from South India. Vijay V, Vigneswari A, Selvan K, Satyavani K,. Rajeswari R, Anil Kapur. Journal of Diabetes and Its Complications 28 (2014) 162–165. - PMID: 24461545
  • Incidence of cardiovascular diseases and associated risk factors among subjects with type 2 diabetes e An 11-year follow up study. Umamahesh K, Vigneswari A, Surya Thejaswi G, Satyavani K, Vijay V. Indian heart journal 2014; 66: e 5- 10 - PMID: 24035281
  • Direct cost associated with chronic kidney disease among type 2 diabetic patients in India. Satyavani K, Hemalatha K, Jayaraman M, Vijay V. Indian J Nephrology 2014; 24(3): 141 – 147.
  • Global guideline for type 2 diabetes. International Diabetes Federation Guideline Development Group. Diabetes Res Clin Pract. 2014 Apr;104(1):1-52. -PMID: 24508150
  • Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Pareek A, Chandurkar N, Thomas N, Vijay V, Deshpande A, Gupta OP, Shah A, Kakrani A, Bhandari S, Thulasidharan NK, Saboo B, Devaramani S, Vijaykumar NB, Sharma S, Agrawal N, Mahesh M, Kothari K. Curr Med Res Opin. 2014 Jul;30(7):1257-66 - PMID: 24669876
  • Comparison of plasma adiponectin & certain inflammatory markers in angiographically proven coronary artery disease patients with & without diabetes – A study from India. Satyavani K, Kirubakaran K, Sathyamurthy I, Parthiban M, Jayanthi K, Srinivasan KN, Vijay V. Ind J Medical Research 2014; 139: 841 – 850 - PMID: 25109718
  • Insulin Degludec – A novel ultra – long acting basal insulin analogue. Vijay V, TAPIJ 2014; 6(1): 6 – 10.
  • An aggressive and multi-pronged approach to prevent amputation in India. Vijay V. IJDDC 2014; 33(3): 123-124
  • An interesting case of hyponatremia. Jaiganesh M, TAPIJ 2014; 6(2): 22 – 24.
  • Rodiographic abnormalities in the feet of diabetic patients with neuropathy and foot ulceration. Vijay V, Satyavani K. Narayana Rao N. JAPI 2014; 62(11): 30-34 PMID: 26281477
  • Opportunistic screening of legal professional for diabesity and hypertension. Vijay V, Muruganathan A, Manikandan R, Vigneswari A, Satyavani K. TAPI J 2014; 6(3): 15 – 18.
  • A Simple and Specific Method for Estimation of Lipoic Acid in human Plasma by High Performance Liquid Chromatography. Ezhilarasi K, Sudha V, Geetha Ramachandran, Dhamodharan U, Rama Rajaram, Indira Padmalayam, Vijay V and Hemanth Kumar AK. J Chromat Separation Techniq 2014; 5( 6): 1000245 (Open Access journal)
  • Effect of a comprehensive training programme for tuberculosis health care providers and tuberculosis patients on diabetes – a report from south India. Vijay V, Vigneswari A, satyavani K, selvan K, Rajeswari R, Kapur A. Int J of Tropical Dis 2015; 5(1): 91-100
  • Double burden of diabetes and TB – Experience in India. Vijay V, Satyavani S, Anitha R. Diabetes Voice 2015; 60(1): 22 – 24.
  • Preventing microvascular complications in type1diabetes mellitus. Vijay V. Ind J Endo and metabolism 2015, vol 19(suppli1): S36 – 38. PMID: 25941647
  • Type 1 diabetes: Awareness, management and challenges: Current scenario in India. K.M. Prasanna Kumar, Banshi Saboo, P.V. Rao, Archana Sarda, Vijay V, Sanjay K, Bipin Sethi, Nalini Shah, S.S. Srikanta, Sunil M Jain, P. Raghupathy, Rishi Shukla, Ashok Jhingan, Subhankar Chowdhury, P.K. Jabbar, Alok Kanungo, Rajesh Joshi, Surendra Kumar, Nikhil Tandon, Vaman Khadilkar, Manoj Chadha. Ind J Endo & Metabolism, 2015;19(supli1):S6 – 8. PMID 25941655
  • Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.Grek CL, Prasad GM, Vijay V, Armstrong DG, Gourdie RG, Ghatnekar GS.Wound Repair Regen. 2015 Mar;23(2):203-12. PMID: 25703647
  • Genetic association of IL-6, TNF-α and SDF-1 polymorphisms with serum cytokine levels in diabetic foot ulcer. Umapathy Dhamodharan, Vijay Viswanathan, Ezhilarasi Krishnamoorthy, Rama Rajaram, Vivekanandhan Aravindhan. Gene, 2015 Jul 1;565(1):62-7. PMID: 25839939
  • An assessment of fear of self injecting and self testing in insulin treated diabetic patients and its impact on HbA1c. Sripriya S, Anu Jij, Satyavani K, Vijay V. TapiJ 2015; 7(1): 1 – 4.
  • Clinical significance of urinary liver‑type fatty acid binding protein at various stages of nephropathy Vijay V, S Sivakumar, V Sekar, D Umapathy1, S Kumpatla Ind J Nephrology 2015; 25(5): 269-273.
  • Novel insulin co-formulation of insulin degludec and insulin aspart (IDegAsp): advancement in diabetes management. Vijay V. TapiJ 2015; 7(2): 1-9.
  • Impact of the hypoxia inducible factor-1α (HIF-1α) pro582ser polymorphism and its gene expression on diabetic foot ulcers. Pichu S, Jayalalitha S, Ezhil K, Dhamodharan U, Vijay V. Diabetes Res Clin Pract. 2015 Sep;109(3):533-40
  • Prevalence of risk factors of diabetes among urban Poor South Indian population A Vigneswari, R Manikandan, K Satyavani, S Archana, R Rajeswari, Vijay V. Japi 2015; 63(10): 32-34.
  • Global Increase in the Prevalence of Diabetes with Special Reference to the Middle East and Asia. Vijay V, Saigopal S. Diabetes Technol Ther. 2015 Oct;17(10):676-8.
  • Effect of yogasanas on glycaemic, haemodynamic and lipid profile in newly diagnosed subjects with type 2 diabetes. Satyavani K, Clementina M, Vijay V. IJDDC, 2015; 35( Suppl 2), pp 181-188
  • Assessment of depression among type 2 diabetic patients with complications and without complications. Sripriya S, Elayaraja B, Satyavani K, Vijay V. IJDDC 2015, Volume 35, Issue 3, pp 310-313
  • 15. Sex differences in cardiovascular risk factors among people with diabetes in South India. Satyavani K, Archana S, Ajay MV Kumar, Shanta A, Vijay V. Japi 2015; 63(12): 20 – 24.
  • Effect of structured behaviour intervention program on Childhood Obesity. Vijay V, Khan BKS, Vigneswari A, Selvan K, Rajeswari R. Saigopal S. Int J of TRO DIS & Health 2016; 11(4): 1-8.
  • Socio-Economic Factors Relating to Diabetes and its Management in India. Shrivastava U, Misra A, Gupta R, Vijay V. J Diabetes. 2016; Vol: 8(1): 12-23 PMID: 26019052
  • High Prevalence and Heterogeneity of Diabetes in TB Patients from South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study. Kornfeld H, West K, Kane K, Kumpatla S, Zacharias RR, Martinez-Balzano C, Li W, Viswanathan V. Chest. 2016; 149(6): 1501-8. PMID: 26973015
  • “Living with type 1 diabetes: Life story of Pallavi” Journal of Social Health and Diabetes / Vol 4 / Issue 1 / Jan-Jun 2016
  • Use of Retrospective Continuous Glucose Monitoring for Optimizing Management of Type 2 Diabetes in India. Mohan V, Sunil Jain, Jothydev K, Manoj C, Abhay M, Vijay V, Banshi S, Rajiv K, Ambrish M, Dharmen P, John S. JAPI 2016: 64(4): 16 – 21. PMID: 27734636
  • Double burden of diabetes and tuberculosis. Vijay V, Saigopal S, Satyavani K. World Clinics Diabetology 2016; 2(1): 23-29. ISBN : 9789352501649
  • Diabetes – an ancient disease, epicdemic & an economic burden for the present era. Vijay V and Smriddhi Ranjan. Ind J Med Res, 2016; 143(4): 11-13. PMID: 27377490
  • Presence of elevated non-HDL among patients with T2DM with CV events despite of optimal LDL-C – A report from South India. Satyavani K, Anju Soni, S.N. Narasingan, Vijay V. Indian Heart J. 2016 May-Jun; 68(3): 378–379. PMID: 27316499
  • Optimizing Technology Use for Chronic Lower-Extremity Wound Healing: A Consensus Document. Mani R, Margolis DJ, Shukla V, Akita S, Lazarides M, Piaggesi A, Falanga V, Teot L, Xie T, Bing FX, Romanelli M, Attinger C, Han CM, Lu S, Meaume S, Xu Z,Vijay V. Int J Low Extrem Wounds. 2016 Jun;15(2):102-19. Review. PMID: 27207900
  • Dual role of transforming growth factor (TGFβ) in diabetic nephropathy – A Review. Anitha rani A and Vijay V. TAPIJ 2016; 8 (1) Jan – Apirl: 5 – 10.
  • Best practices from Changing Diabetes® in Children India K. M. Prasanna Kumar, Nalini Shah, Vijay V, Archana Sarda, Shuchy Chugh, Dinakaran P. J Social Health and Diab 2016, 4 (2): 137-140
  • Effect of standard tuberculosis treatment on naive, memory and regulatory T cell homeostasis in tuberculosis-diabetes co-morbidity. Kumar NP, Moideen K Vijay V, Kornfeld H, Babu S. Immunology. 2016 Sep;149(1): 87-97. PMID: 27289086
  • Impact of the Gather mHealth System on A1C: Primary Results of a Multisite Randomized Clinical Trial Among People With Type 2 Diabetes in India. Kleinman NJ, Shah A, Shah S, Phatak S, Vijay V. Diabetes Care. 2016 Oct;39(10): e169-70. PMID: 27493133
  • Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial. Ali MK, Singh K, Kondal D, Devarajan R, Patel SA, Shivashankar R, Ajay VS, Unnikrishnan AG, Menon VU, Varthakavi PK, Viswanathan V, Dharmalingam M, Bantwal G, Sahay RK, Masood MQ, Khadgawat R, Desai A, Sethi B, Prabhakaran D, Narayan KM, Tandon N; CARRS Trial Group. Ann Intern Med. 2016 Sep 20; 165 (6):399-408. PMID: 27398874.
  • Replication of genome-wide association signals in Asian Indians with early-onset type 2 diabetes. Chidambaram M, Samuel Liju, Banshi Saboo, Satyavani K, Vijay V, Pankratz N, Myron Gross, Mohan V. Acta Diabetol 2016; Dec 53(6): 915 - 923. PMID:27488727
  • Effect of a polyherbal formulation cream on diabetic neuropathic pain among patients with type 2 diabetes - A pilot study. Vijay V, Seena R, Bamila S, Satyavani K. IJMR 2016; 144(2): 215 – 219.
  • Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment. Kumar NP, Moideen K, Sivakumar S, Menon PA, Vijay V, Kornfeld H, Babu S. Tuberculosis (Edinb). 2016; Dec 101: 191-200. PMID: 27865391
List Of International Publications
  • Shabana Tharkar, Karunanithi Kathiresan, Pintochan Abraham, Vijay Viswanathan, Development & Evaluation of a training programme on Primary Prevention of Diabetes for Primary Care Physicians - IJHR December 2009; 2(4): 305-314.
  • Shabana Tharkar, Vijay Viswanathan - Impact of socioeconomic status on prevalence of overweight and obesity among children and adolescents in urban India - The Open Obesity Journal, 2009,1, 9-14.
  • Shabana Tharkar, Kumpatla Satyavani, Vijay Viswanathan - Cost of Medical Care among type-2 diabetic patients with a co-morbid condition - Hypertension in India (ELSEVIER) Diabetes Research & Clinical Practice 83 (2009) 263-267.
  • Vijay V, Snehalatha C, Ramachandran A, Viswanathan M. Proteinuria in NIDDM in south India: analysis of predictive factors. Diabetes Research and Clinical Practice 1995; 28: 41 - 46.
  • Vijay V, Snehalatha C, Terin M, Ramachandran A. Does the presence of diabetic nephropathy in patients influence the metabolic response in the offspring? Diabetic Medicine 14: 854 - 857, 1997.
  • Vijay V, Snehalatha C, Terin M, Muthu J, Ramachandran A. Cardiovascular morbidity in proteinuric south Indian NIDDM patients. DRCP 39 (1998), 63 - 67.
  • Vijay V, Snehalatha C, Terin M, Muthu J, Ramachandran A. Serum sialic acid in south India type 2 diabetic patients with microvascular complication. Diabetic Medicine 1998; 15: 176.
  • Vijay v, Seena R, Lalitha S, Snehalatha C, Muthu J, Ramachandran A. Significance of Microalbuminuria at diagnosis of type 2 diabetes. Diabetes bulletin, International Journal of Diabetes in developing countries 1998; 18: 5 - 6.
  • Vijay V, Shina K, Lalitha S, Snehalatha C, Ramachandran A. Familial aggregation of diabetes kidney disease in south India. DRCP 1999; 43: 167 - 171.
  • Vijay Viswanathan. Type 2 diabetes and diabetic nephropathy in India - magnitude of the problem. Nephrol Dial Transplant (1999) 14: 2805 - 2807.
  • Vijay Viswanathan, Durga Prasad, Snehalatha C, A. Ramachandran. High prevalence and early onset of cardiac autonomic neuropathy among south Indian type 2 diabetic patients with nephropathy. DRCP 48 (2000); 211 - 216.
  • Vijay Viswanathan, Snehalatha C, Ramachandran A, Shina K. Evaluation of simple, random urine test for prospective analysis of proteinuria in type 2 diabetes six years follow up study. DRCP 49 (2000); 143 - 147.
  • Vijay Viswanathan, C Snehalatha, A Ramachandran. Diabetic nephropathy - strategy of management. Int. J. Diab. Dev. Countries 2000; 20.
  • Vijay Viswanathan, Yanqing Zhu, Karthik Bala, Stephen Dunn, C Snehalatha, A. Ramachandran, Muthu Jayaraman, Kumar Sharma. Association between ACE gene polymorphism & diabetic nephropathy in south Indian patients. JOP. J. Pancreas (Online) 2001; 2 (2): 83 - 87.
  • Vijay Viswanathan, C Snehalatha, R Suresh Mohan, B Mamtha Nair, A Ramachandran. Increased carotid intimal media thickness precedes albuminuria in south Indian type 2 diabetic subjects. The British Journal of Diabetes and vascular disease Vol 3, issue 2, March / April 2003, pg: 146 - 149.
  • Vijay Viswanatha, C Snehalatha, Mamtha B. Nair, A Ramachandra. Markers of endothelial dysfunction in hyperglycaemic Asian Indian subjects. Journal of Diabetes and its Complications 2004: 18 (1), 47 - 52.
  • B. Mamtha Nair, Vijay Viswanathan, C Snehalatha, R Suresh Mohan, A Ramachandran. Flow Mediated dilatation and carotid intimal media thickness in south Indian type 2 diabetic subjects. DRCP 2004; 25: 13 - 19.
  • Vijay Viswanathan, Mamtha B Nair, Sheethal Suresh, Snehalatha C, Ramachandran A. An inexpensive method to diagnose incipient diabetic nephropathy in developing countries. Diabetes Care 2005; 28: 1259 - 1260.
  • Vijay Viswanathan, C Snehalatha, Mamtha B Nair, R Kumutha, A Ramachandran. Levels of transforming growth factor beta 1 in south Indian type 2 diabetic subjects. Diabetes Metab Res Rev 2005; 21: 276 - 280.
  • Vijay V, Snehalatha C, Terin M, Ramachandran A. Socio - cultural practices that may affect the development of the diabetic foot. IDF Bulletin 1997: 42 ; 10 -12.
  • Vijay V, Seena R, Lalitha S, Snehalatha C, Ramachandran A. A simple device for foot pressure measurement: Evaluation in south Indian NIDDM subjects. Diabetes care 1998: 21; 1205 - 6.
  • Vijay Viswanathan, D.V.L. Narasimhan, R. Seena, C. Snehalatha and A. Ramachandran. Clinical profile of diabetic foot infection in south India - a restropective study. Diabetic Medicine 17 (5): 2000; 215 - 218.
  • Vijay V, Snehalatha C, Seena R, Ramachandran A. The Rydel Seiffer tuning fork: an inexpensive device for screening diabetic patients with high - risk foot - Practical Diabetes Int. 2001: 18 (5); 155 - 156.
  • Vijay Viswanathan, Seena Rajasekar, C. Snehalatha, A. Ramachandran. Routine foot examination: the first step towards prevention of diabetic foot amputation. Pract Diab Int June 2001. Vol 17, No.4.
  • Vijay Viswanathan, C. Snehalatha, M. Sivagami, R Seena, A. Ramachandran. Association of limited joint mobility and high plantar pressure in diabetic foot ulceration in Asian Indians. Diabetes research and clinical practice, April 2003; 60 (1), pg 57 - 61.
    S. Morbach, J.K. Lutalet, Vijay Viswanathan, J. Mollenberg, H.R. Ochs, Seena Rajasekar, A. Ramachandran, Z.G. Abbas. Regional differences in risk factors and clinical presentation of diabetic foot lesions. Diabetic medicine 2003; 21: 91 - 95.
  • Vijay Viswanathan, Sivagami M, Saraswathy G, Gautham G, Das B N, Seena R, Ramachandran A. Effectiveness of different types of footwear insoles for the diabetic neuropathic foot. Diabetes care 2004; 27: 474 - 477.
  • Vijay Viswanathan, M. Sivagami, R Seena, C. Snehalatha, A Ramachandran and A Veves. Increased forefoot to rearfoot plantar pressure ratio in south Indian patients with diabetic foot ulceration. Diabetic medicine 2004; 21: 396 - 397.
  • Vijay Viswanathan, Sivagami M, Seena R, Snehalatha C, Ramachandran A. Amputation prevention initiative in south India : Positive impact of foot care education. Diabetes care 2005; 28: 1019 - 1021.
  • Vijay Viswanathan, Sivagami Madhavan, Seena Rajasekar, Snehalatha Chamukuttan, Ambady Ramachandran. Urban - Rural differences in the prevalence of foot complications in south Indian diabetic patients. Diabetes care 2006; 29: 701 - 703.
  • Vijay Viswanathan, Sharad Pendsey, N. Sekar, G.S.R Murthy. A phase III study to evaluate the safety and efficacy of recombinant human epidermal growth factor (REGEN - DTM 150) in healing diabetic foot ulcers. Wounds 2006; 18 (7): 186 - 196.
  • Vijay Viswanathan. The Diabetic Foot. International Journal of Lower Extermity Wounds, 2007; 6 : 34 - 36.
ATTRACTIVE DIABETES PACKAGES CLICK HERE FOR QUICK Appointment Consultants CORPORATE/CASHLESS TIE-UPS Unique Amputation prevention

Testimonials

MV HospitalVery good work is being done here for diabetic patients.
Mrs. Pratibha Patil

MV Hospital

Manmohan Singh"Message from Honourable Ex Prime Minister of India Dr.Manmohan Singh"

MV Hospital

Our Products

News & Events

  • On the occasion of the 40 years diabetes research by DRC, Life Time Achievement Award was presented...

  • Prof. Samad Shera, Director & Secretary General, Diabetes Association of Pakistan, Head, WHO Collaborating Centre...

  • Healthcare delegation from Bexar County Medical Society, San Antonio visited on 25th January 2013

MV Hospital